Literature DB >> 984862

Induction of glycosuria and hyperglycemia by topical corticosteroid therapy.

E C Gomez, P Frost.   

Abstract

A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed postprandial hyperglycemia and glycosuria during a period of topical administration of a corticosteroid cream, halcinonide cream 0.1%, under occlusion. A second patient with a similar glucose tolerance test result showed postprandial hyperglycemia when treated similarly with betamethasone valerate cream 0.1%. Two additional patients with midly abnormal responses to glucose tolerance tests showed no evidence of altered glucose metabolism when treated with halcinonide cream in a similar manner.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984862

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

Review 1.  Anti-inflammatory glucocorticoid drugs: reflections after 60 years.

Authors:  Michael W Whitehouse
Journal:  Inflammopharmacology       Date:  2010-10-31       Impact factor: 4.473

2.  Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Authors:  H Schäcke; T M Zollner; W D Döcke; H Rehwinkel; S Jaroch; W Skuballa; R Neuhaus; E May; U Zügel; K Asadullah
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

Review 3.  Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review.

Authors:  K L Goa
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Authors:  Gil Yosipovitch; Mark B Y Tang
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study.

Authors:  W-Q Li; J-L Han; J E Manson; E B Rimm; K M Rexrode; G C Curhan; A A Qureshi
Journal:  Br J Dermatol       Date:  2012-04       Impact factor: 9.302

6.  Pharmacotherapy-Based Problems in the Management of Diabetes Mellitus: Needs Much More to be Done!

Authors:  N Ali; Swa Shah; J Khan; S Rehman; M Imran; I Hussian; N Shehbaz; H Jamshed; S Khan
Journal:  J Young Pharm       Date:  2010-07

7.  Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands.

Authors:  Michiel W van der Linden; Fernie J A Penning-van Beest; Tamar Nijsten; Ron M C Herings
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study.

Authors:  Wenqing Li; Jiali Han; Frank B Hu; Gary C Curhan; Abrar A Qureshi
Journal:  J Invest Dermatol       Date:  2011-10-13       Impact factor: 8.551

9.  Acute Hyperglycemia Due to Topical Corticosteroid Administration.

Authors:  Laura Y Sue; Anna Milanesi
Journal:  Case Rep Endocrinol       Date:  2019-01-02

Review 10.  Consensus Conference on Clinical Management of pediatric Atopic Dermatitis.

Authors:  Elena Galli; Iria Neri; Giampaolo Ricci; Ermanno Baldo; Maurizio Barone; Anna Belloni Fortina; Roberto Bernardini; Irene Berti; Carlo Caffarelli; Elisabetta Calamelli; Lucetta Capra; Rossella Carello; Francesca Cipriani; Pasquale Comberiati; Andrea Diociaiuti; Maya El Hachem; Elena Fontana; Michaela Gruber; Ellen Haddock; Nunzia Maiello; Paolo Meglio; Annalisa Patrizi; Diego Peroni; Dorella Scarponi; Ingrid Wielander; Lawrence F Eichenfield
Journal:  Ital J Pediatr       Date:  2016-03-02       Impact factor: 2.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.